Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

McNeil Products Ltd
Foundation Park, Roxborough Way, Maidenhead, Berks, SL6 3UG
Medical Information Direct Line: 01344 864042
Medical Information e-mail: medinfo@its.jnj.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 03/04/2008
SPC Benadryl Allergy Relief

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/04/2008 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Date of revision of text on the SPC:   03/2008
Legal Category:   GSL/P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Change to MA as a result of integration
Updated on 03/04/2008 and displayed until 03/04/2008
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Date of revision of text on the SPC:   03/2008
Legal Category:   GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Change to MA as a result of integration
Updated on 13/09/2006 and displayed until 03/04/2008
Reasons for adding or updating:
  • Change to section 10 (date of (partial) revision of the text
Date of revision of text on the SPC:   02/2005
Legal Category:   GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 10 Change to date of revision of text
Updated on 14/09/2005 and displayed until 13/09/2006
Reasons for adding or updating:
  • Change to section 10 (date of (partial) revision of the text
Updated on 09/09/2005 and displayed until 14/09/2005
Reasons for adding or updating:
  • Change to section 10 (date of (partial) revision of the text
Updated on 08/09/2005 and displayed until 09/09/2005
Reasons for adding or updating:
  • Change to section 10 (date of (partial) revision of the text
Updated on 28/09/2004 and displayed until 08/09/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 16/01/2004 and displayed until 28/09/2004
Reasons for adding or updating:
  • Change to section 5.1 - Pharmacodynamic Properties
Updated on 26/09/2002 and displayed until 16/01/2004
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 16/09/2002 and displayed until 26/09/2002
Reasons for adding or updating:
  • Change to section 10 (date of (partial) revision of the text
  • Change to section 7 - Marketing Authorisation Holder
Updated on 28/08/2001 and displayed until 16/09/2002
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
  acrivastine